Get the Stockscreener App
14.96
0.07%
-0.010
Afya Ltd stock is traded at $14.96, with a volume of 116.37K.
It is down -0.07% in the last 24 hours and up +11.48% over the past month.
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.
See More
Previous Close:
$14.97
Open:
$14.86
24h Volume:
116.37K
Relative Volume:
1.01
Market Cap:
$1.34B
Revenue:
$661.97M
Net Income/Loss:
$136.88M
P/E Ratio:
10.39
EPS:
1.4396
Net Cash Flow:
$159.27M
1W Performance:
+0.13%
1M Performance:
+11.48%
6M Performance:
-2.54%
1Y Performance:
-18.74%
1-Day Range:
$14.79
$15.26
1-Week Range:
$14.52
$15.26
52-Week Range:
$13.00
$19.90
Afya Ltd Stock (AFYA) Company Profile
Name
Afya Ltd
Sector
Industry
Phone
-
Address
-
Compare AFYA vs EDU, TAL, LAUR, LOPE, GHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AFYA
Afya Ltd
|
14.96 | 1.34B | 661.97M | 136.88M | 159.27M | 1.4396 |
EDU
New Oriental Education Technology Group Inc Adr
|
56.42 | 8.98B | 5.15B | 405.45M | 918.66M | 2.3741 |
TAL
Tal Education Group Adr
|
11.20 | 6.82B | 2.82B | 278.91M | 591.92M | 0.4868 |
LAUR
Laureate Education Inc
|
33.56 | 4.79B | 1.70B | 283.82M | 263.15M | 1.9154 |
LOPE
Grand Canyon Education Inc
|
171.36 | 4.65B | 1.11B | 216.17M | 238.59M | 7.7173 |
GHC
Graham Holdings Co
|
1,060.93 | 4.61B | 4.91B | 301.63M | 267.66M | 66.42 |
Afya Ltd Stock (AFYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-24-26 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-13-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-16-26 | Downgrade | UBS | Buy → Neutral |
| Jan-07-26 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-08-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-08-25 | Upgrade | UBS | Neutral → Buy |
| Aug-06-25 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Jul-29-25 | Upgrade | Citigroup | Sell → Neutral |
| Mar-11-25 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-31-25 | Downgrade | Citigroup | Neutral → Sell |
| Dec-03-24 | Initiated | Goldman | Sell |
| Aug-30-24 | Initiated | UBS | Neutral |
| Jan-29-24 | Initiated | Citigroup | Neutral |
| Jan-22-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-13-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-08-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-21-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-15-21 | Upgrade | UBS | Neutral → Buy |
| Feb-04-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-19-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-28-20 | Upgrade | Goldman | Neutral → Buy |
| Sep-15-20 | Resumed | BofA Securities | Buy |
| Aug-19-20 | Initiated | Credit Suisse | Neutral |
| May-20-20 | Downgrade | UBS | Buy → Neutral |
| Mar-20-20 | Upgrade | Itau BBA | Market Perform → Outperform |
| Jan-23-20 | Resumed | BofA/Merrill | Buy |
| Sep-19-19 | Initiated | UBS | Buy |
| Aug-13-19 | Initiated | BofA/Merrill | Buy |
| Aug-13-19 | Initiated | Goldman | Neutral |
| Aug-13-19 | Initiated | Morgan Stanley | Overweight |
| Aug-09-19 | Initiated | JP Morgan | Overweight |
View All
Afya Ltd Stock (AFYA) Latest News
Afya Limited (NASDAQ:AFYA) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Afya Limited (NASDAQ:AFYA) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
Afya (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon Sells 2,320 Shares - MarketBeat
Afya (AFYA) CEO sells 21,820 shares, retains significant stake - Stock Titan
Afya (Nasdaq: AFYA) flags Brazil tax, PROUNI/FIES and MEC exam risks - Stock Titan
Afya (AFYA) CEO trims holdings with 1,810-share open-market sale - Stock Titan
Afya (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon Sells 3,900 Shares of Stock - Defense World
Afya (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon Sells 800 Shares - MarketBeat
Virgilio Deloy Capobian Gibbon Sells 3,900 Shares of Afya (NASDAQ:AFYA) Stock - MarketBeat
XP Investments lists 36,000 S-8 shares for sale (NASDAQ: AFYA) - Stock Titan
Afya (AFYA) CEO sells 4,700 Class A shares, retains over 350,000 total - Stock Titan
AFYA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Should Value Investors Buy Afya (AFYA) Stock? - Yahoo Finance
Afya (NASDAQ:AFYA) Shares Gap DownShould You Sell? - MarketBeat
Afya Limited (NASDAQ: AFYA) files Form 144 proposing sale of Class A shares - Stock Titan
[Form 3/A] Afya Ltd Amended Initial Statement of Beneficial Ownership - Stock Titan
Afya Limited (NASDAQ:AFYA) Plans Annual Dividend of $0.66 - MarketBeat
AFYA News & Events - Intellectia AI
Afya (AFYA) vice president details options, RSUs and 43,032 shares - Stock Titan
Afya (AFYA) VP details stock options, RSUs and share holdings - Stock Titan
Afya (AFYA) director Marcelo Ken Suhara files initial Form 3 ownership report - Stock Titan
Afya (NASDAQ: AFYA) VP Del Bianco lists stock, option and RSU stakes - Stock Titan
Afya (AFYA) director files initial insider ownership report with no trades - Stock Titan
Afya (NASDAQ: AFYA) VP details initial share, option and RSU holdings - Stock Titan
Afya (AFYA) controller discloses stock options, RSUs and shares - Stock Titan
Afya (AFYA) vice president discloses initial share, RSU and option stakes - Stock Titan
Afya (AFYA) CEO details shares, options and RSUs in initial Form 3 - Stock Titan
Afya (AFYA) vice president reports stock options, RSUs and share stake - Stock Titan
Afya (AFYA) director Christina Bacon Krebs files initial insider Form 3 - Stock Titan
Afya (AFYA) VP details Class A shares, options and RSU holdings - Stock Titan
Afya (NASDAQ: AFYA) director Carvalho reports initial direct and indirect stakes - Stock Titan
Afya (AFYA) director discloses 1.26M Class A share stake - Stock Titan
Afya (NASDAQ: AFYA) CFO reports option, RSU and share holdings - Stock Titan
Afya Ltd (AFYA) director Krafft Kay Christian submits initial Form 3 - Stock Titan
Afya Ltd (AFYA) director Pereira de Paula Miguel Filisbino files Form 3 - Stock Titan
Afya (AFYA) director Vanessa Claro Lopes files Form 3 ownership report - Stock Titan
Afya (AFYA) director identified as reporting insider in Form 3 filing - Stock Titan
Afya Limited (NASDAQ:AFYA) Sees Significant Growth in Short Interest - MarketBeat
AFYA SEC FilingsAfya Limited 10-K, 10-Q, 8-K Forms - Stock Titan
Afya (AFYA) affiliate plans sale of 150,000 Class A shares on Nasdaq - Stock Titan
Doma Perpetual Capital Management LLC Boosts Position in Afya Limited $AFYA - MarketBeat
Bamco Inc. NY Cuts Stock Holdings in Afya Limited $AFYA - MarketBeat
Afya (NASDAQ:AFYA) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
Afya Ltd (AFYA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments By GuruFocus - Investing.com Canada
Afya Limited 2025 Q4ResultsEarnings Call Presentation (NASDAQ:AFYA) 2026-03-13 - Seeking Alpha
Earnings Call Summary | Afya Ltd(AFYA.US) Q4 2025 Earnings Conference - 富途牛牛
Afya Q4 2025 Earnings: $32.5M Net Income, $169M Revenue | Full Year ResultsNews and Statistics - IndexBox
Afya Ltd. Hits New 52-Week Low at USD 13.01 Amid Decline - Markets Mojo
Afya Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
Afya: Q4 Financial Results Overview - Bitget
Afya: Q4 Earnings Snapshot - WHAS11
Afya Ltd Stock (AFYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Afya Ltd Stock (AFYA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Gibbon Virgilio Deloy Capobian | Chief Executive Officer |
Mar 31 '26 |
Sale |
14.92 |
2,320 |
34,614 |
149,618 |
| Gibbon Virgilio Deloy Capobian | Chief Executive Officer |
Mar 30 '26 |
Sale |
14.91 |
1,510 |
22,514 |
151,938 |
| Gibbon Virgilio Deloy Capobian | Chief Executive Officer |
Mar 27 '26 |
Sale |
15.00 |
300 |
4,500 |
153,448 |
0.84%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):